CYTOKINETICS

cytokinetics-logo

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.

#SimilarOrganizations #People #Financial #Website #More

CYTOKINETICS

Social Links:

Industry:
Biopharma Biotechnology Health Care

Founded:
1998-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.cytokinetics.com

Total Employee:
51+

Status:
Active

Contact:
6506243010

Total Funding:
1.14 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

rheos-medicines-logo

Rheos Medicines

A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.

not_available_image

Resolution Therapeutics

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

reset-therapeutics-logo

Reset Therapeutics

Reset Therapeutics, a biopharmaceutical company, develops and commercializes products that modulate the circadian system of the human body.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

roivant-sciences-logo

Roivant Sciences

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

relypsa-logo

Relypsa

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

neximmune-logo

NexImmune

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

nrx-pharmaceuticals-logo

NRx Pharmaceuticals

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

neuropore-therapies-logo

Neuropore Therapies

San Diego-based Neuropore, a biopharmaceuticals firm developing treatments for Parkinson's disease.

vir-biotechnology-logo

Vir Biotechnology

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

vivet-therapeutics-logo

Vivet Therapeutics

Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

marinomed-logo

Marinomed

Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

moerae-matrix-logo

Moerae Matrix

Moerae Matrix is a biopharmaceutical company developing targeted therapeutics for fibrotic diseases.

lumos-pharma-logo

Lumos Pharma

Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.

artax-biopharma-logo

Artax Biopharma

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

ambit-biosciences-logo

Ambit Biosciences

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.

ataxion-logo

Ataxion

Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.

algorithm-sciences-logo

Algorithm Sciences

Algorithm Sciences is a biopharmaceutical company that focuses on treatment for rare cardiovascular diseases.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

apexigen-logo

Apexigen

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

anavex-logo

Anavex

Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.

arrakis-therapeutics-logo

Arrakis Therapeutics

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.

ablynx-logo

Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.

arno-therapeutics-logo

Arno Therapeutics

Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.

antios-therapeutics-logo

Antios Therapeutics

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

akeso-biopharma-logo

Akeso Biopharma

Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

aileron-therapeutics-logo

Aileron Therapeutics

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

aeterna-zentaris-logo

AEterna Zentaris

AEterna Zentaris is a drug development company that specializes in oncology and endocrine therapy.

amicus-therapeutics-logo

Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

evofem-biosciences-logo

Evofem Biosciences

Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

epizyme-logo

Epizyme

Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.

endonovo-therapeutics-logo

Endonovo Therapeutics

Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products.

escape-bio-logo

ESCAPE Bio

ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.

biontech-logo

BioNTech

BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.

bone-therapeutics-logo

Bone Therapeutics

Bone Therapeutics is a biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.

tracon-pharmaceuticals-logo

TRACON Pharmaceuticals

TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.

trillium-therapeutics-logo

Trillium Therapeutics

Trillium is a biotech company focused on developing therapy treatments for cancer.

touchlight-genetics-logo

Touchlight Genetics

Touchlight Genetics, a British bio-pharmaceutical company founded in 2007.

taris-biomedical-logo

TARIS Biomedical

TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.

tetraphase-pharmaceuticals-logo

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.

transition-therapeutics-logo

Transition Therapeutics

Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.

theravance-biopharma-logo

Theravance Biopharma

Theravance Biopharma is a biopharmaceutical company with one approved product.

trevena-logo

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.

cogent-biosciences-logo

Cogent Biosciences

Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.

urovant-sciences-logo

Urovant Sciences

Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.

kiadis-pharma-logo

Kiadis Pharma

Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.

kindred-biosciences-logo

Kindred Biosciences

Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.

krystal-biotech-logo

Krystal Biotech

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

humanigen-logo

Humanigen

Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.

kamada-logo

Kamada

Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique

kojin-therapeutics-logo

Kojin Therapeutics

Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.

wren-therapeutics-logo

Wren Therapeutics

Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.

springworks-therapeutics-logo

SpringWorks Therapeutics

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

spruce-biosciences-logo

Spruce Biosciences

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

synaptogenix-logo

Synaptogenix

Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

silverback-therapeutics-logo

Silverback Therapeutics

Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.

spectrum-pharmaceuticals-logo

Spectrum Pharmaceuticals

Spectrum Pharmaceuticals is a biopharmaceutical company developing drugs to treat oncology and hematology.

palisade-bio-logo

Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.

synergy-pharmaceuticals-logo

Synergy Pharmaceuticals

Synergy Pharmaceuticals is a biopharmaceutical company developing novel therapies for the treatment of gastrointestinal conditions.

sitari-pharmaceuticals-logo

Sitari Pharmaceuticals

Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

dynavax-technologies-logo

Dynavax Technologies

Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.

dianthus-therapeutics-logo

Dianthus Therapeutics

Dianthus Therapeutics is a biotech company developer of therapeutics and drugs.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

dare-bioscience-logo

Dare Bioscience

Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.

deciduous-therapeutics-logo

Deciduous Therapeutics

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

histogenics-logo

Histogenics

Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.

harmony-biosciences-logo

Harmony Biosciences

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

horizon-therapeutics-logo

Horizon Therapeutics

Horizon Therapeutics is a biopharmaceutical company driven to deliver breakthrough medicines to patients.

virios-therapeutics-logo

Virios Therapeutics

Virios Therapeutics is a clinical-stage biopharmaceutical company developing novel antiviral therapies for fibromyalgia and other diseases.

ifm-therapeutics-logo

IFM Therapeutics

DescriptionIFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.

innovent-biologics-logo

Innovent Biologics

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

genelux-logo

Genelux

Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.

genprex-logo

Genprex

Genprex is a clinical-stage biopharmaceutical company developing revolutionary immunogene therapies for cancer.

gh-research-logo

GH Research

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

glycomimetics-logo

GlycoMimetics

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

gi-dynamics-logo

GI Dynamics

GI Dynamics is a medical device company developing therapies for the treatment of type 2 diabetes and related metabolic diseases.

otonomy-logo

Otonomy

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

onconova-therapeutics-logo

Onconova Therapeutics

Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer.

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

ocera-therapeutics-logo

Ocera Therapeutics

Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.

oncoimmune-logo

OncoImmune

OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.

xylocor-therapeutics-logo

XyloCor Therapeutics

XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.

cellectis-logo

Cellectis

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.

epirium-bio-logo

Epirium Bio

Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

cytocom-logo

Cytocom

Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.

complexa-logo

Complexa

Complexa, a biopharmaceutical company, develops therapies for the treatment of inflammatory, and metabolic diseases.

celtaxsys-logo

Celtaxsys

Celtaxsys is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

compass-therapeutics-inc-logo

Compass Therapeutics, Inc.

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

promedior-logo

Promedior

Promedior is a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases.

peptide-logic-logo

Peptide Logic

Peptide Logic is a biopharmaceutical company developing peptide-antibody conjugates for pain.

paratek-pharmaceuticals-logo

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies.


Current Advisors List

b-lynne-parshall_image

B. Lynne Parshall Member of the Board of Directors @ Cytokinetics
Board_member

not_available_image

Michael Schmertzler Member of the Board of Directors @ Cytokinetics
Board_member

steve-dow_image

Steve Dow Board of Directors @ Cytokinetics
Board_member

Current Employees Featured

daniel-ramos_image

Daniel Ramos
Daniel Ramos Recruiter @ Cytokinetics
Recruiter
2016-10-01

robert-blum_image

Robert Blum
Robert Blum President & CEO @ Cytokinetics
President & CEO
2007-01-01

not_available_image

Ronald Vale
Ronald Vale Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator @ Cytokinetics
Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator

patrick-gage_image

Patrick Gage
Patrick Gage Chairman of the Board of Directors @ Cytokinetics
Chairman of the Board of Directors
2009-11-01

not_available_image

James Sabry
James Sabry Co-founder, Cytokinetics; Senior Vice President, Genentech Partnering @ Cytokinetics
Co-founder, Cytokinetics; Senior Vice President, Genentech Partnering

Founder


not_available_image

James Sabry

james-spudich_image

James Spudich

lawrence-goldstein_image

Lawrence Goldstein

not_available_image

Ronald Vale

Stock Details


Company's stock symbol is NASDAQ:CYTK

Investors List

royalty-pharma_image

Royalty Pharma

Royalty Pharma investment in Post-IPO Debt - Cytokinetics

deerfield_image

Deerfield

Deerfield investment in Post-IPO Equity - Cytokinetics

federated-kaufmann-fund-2_image

Federated Kaufmann Fund

Federated Kaufmann Fund investment in Post-IPO Equity - Cytokinetics

red-abbey-venture-partners_image

Red Abbey Venture Partners

Red Abbey Venture Partners investment in Post-IPO Equity - Cytokinetics

vulcan-llc_image

Vulcan

Vulcan investment in Series E - Cytokinetics

Official Site Inspections

http://www.cytokinetics.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.53 K

  • Host name: 141.193.213.21
  • IP address: 141.193.213.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Cytokinetics"

Company | Cytokinetics

Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which …See details»

Careers - Cytokinetics

Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community through peer-reviewed journals and medical …See details»

Cytokinetics - Wikipedia

Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. [2] Operations began in 1998. …See details»

Investor Overview | Cytokinetics, Inc.

Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community through peer-reviewed journals and medical …See details»

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

Jan 13, 2025 SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today provided guidance for corporate milestones expected …See details»

Cytokinetics - Crunchbase Company Profile & Funding

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential …See details»

Cytokinetics - Leadership Team - The Org

The Leadership Team at Cytokinetics plays a pivotal role in guiding the company's strategic vision and operational execution. This diverse group comprises executives from various functions, …See details»

Our Vision - Cytokinetics

Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community …See details»

Cytokinetics: Culture - LinkedIn

Cytokinetics | 31,124 followers on LinkedIn. Empowering Muscle Empowering Lives | Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing ...See details»

Cytokinetics - Annual 2025

Cytokinetics What We Do As a leader in muscle biology, Cytokinetics is developing small molecule drug candidates engineered to impact muscle function and contractility.Cytokinetics …See details»

Grants and Giving Programs | Cytokinetics

Funding from the Cytokinetics Communications Grant program supports marketing and communications programming or personnel activities, depending on each organization’s …See details»

Cytokinetics, Inc. Locations - Contract Research Map

280 East Grand Avenue South San Francisco, CA 94080 Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in …See details»

SEC Filings | Cytokinetics, Inc.

Apr 21, 2025 Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and …See details»

Cytokinetics Announces Recipients of Its Seventh Annual …

Jan 30, 2025 Total of $100,000 Awarded to Five Patient Advocacy Organizations to Support Communications and Community Outreach. SOUTH SAN FRANCISCO, Calif., Jan. 30, 2025 …See details»

Cytokinetics - Craft

Oct 29, 2024 Cytokinetics has 5 employees across 2 locations and $18.47 m in annual revenue in FY 2024. See insights on Cytokinetics including office locations, competitors, revenue, …See details»

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

Jan 13, 2025 SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today provided guidance for corporate milestones expected …See details»

Mission - Cytokinetics

Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community …See details»

Cytokinetics Q1 2025 Earnings Preview (NASDAQ:CYTK)

6 hours ago Cytokinetics (CYTK) Q1 earnings set for May 6th. Analysts expect EPS at -$1.36 and revenue growth of 210.7% YoY.See details»

Our Story | Timeline | Cytokinetics

For 25 years, Cytokinetics has been developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle …See details»

Cytokinetics Names Robert E. Landry to Board of Directors

Feb 11, 2025 Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and …See details»

linkstock.net © 2022. All rights reserved